LEVELS OF ACTIVIN A IN THE BLOOD OF SPONTANEOUS ECTOPIC PREGNANCY


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Objective. Comparative the level of activin A in blood at patients with ectopic pregnancy and uteri pregnancy taking into account features of development cytotrophoblast till 7 weeks gestation. Subjects and methods. 38 patients of reproductive age are included in research from 18 till 42 years (30,8±5,3 year). The group of patients with trumpet pregnancy till 7 weeks гестации was made by 16 women, with trumpet pregnancy after 7 weeks - 5 women. Patients with маточной pregnancy: till 7 weeks — 12 women, after 7 weeks — 5. Level of β-hCG in blood serum was carried out immune fluorescent method, progesterone and activin A levels was detection with enzymoimmunoassay. Results. The level of activin A in the blood at spontaneous ectopic pregnancy till 7 weeks does not significant from uteri pregnancy. After 7 weeks level of activin A statistically significant was more low at ectopic pregnancy. Conclusion. The level of activin A in the blood at spontaneous uteri pregnancy should be used for processes cytotrophoblast invasion and placentation at dynamic supervision after 7 weeks gestation.

Full Text

Restricted Access

About the authors

V. A BURLEV

Academican V.I.Kulakov Research Center of Obstetrics, Gynecology and Perinatology, Ministry of Health and Social Development of Russia

Email: vbourlev@mail.ru

N. A ILYASOVA

Academican V.I.Kulakov Research Center of Obstetrics, Gynecology and Perinatology, Ministry of Health and Social Development of Russia

S. V PAVLOVITCH

Academican V.I.Kulakov Research Center of Obstetrics, Gynecology and Perinatology, Ministry of Health and Social Development of Russia

Sh. M RASULOVA

Academican V.I.Kulakov Research Center of Obstetrics, Gynecology and Perinatology, Ministry of Health and Social Development of Russia

References

  1. Серова О.Ф., Кириченко А.К., Ермаченко Л.В., Зароченцева Н.В., Добровольская Т.Б. Внематочная беременность: современные аспекты этиологии патогенеза. Российский вестник акушера-гинеколога. 2006; 2: 19-22.
  2. Atkinson A.J., Colburn W.A., DeGruttola V.G. et al.; Biomarkers Definitions Working Group. Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin. Pharmacol. Ther. 2001; 69(3): 89-95.
  3. Barnhart K., Van Mello N.M., Bourne T., Kirk E., Van Calster B., Bottomley C. et al. Pregnancy of unknown location: a consensus statement of nomenclature, definitions, and outcome. Fertil. Steril. 2011; 95(3): 857-66.
  4. Bearfield C., Jauniaux E., Groome N., Sargent I.L., Muttukrishna S. The secretion and effect of inhibin A, activin A and follistatin on first-trimester trophoblasts in vitro. Eur. J. Endocrinol. 2005; 152(6): 909-16.
  5. Castellucci M., Kosanke G., Verdenelli F., Huppertz B., Kaufmann P. Villous sprouting: fundamental mechanisms of human placental development. Hum. Reprod. Update. 2000; 6(5): 485-94.
  6. Farquharson R.G., Jauniaux E., Exalto N. Updated and revised nomenclature for description of early pregnancy events. Hum. Reprod. 2005; 11(20): 3008-11.
  7. Florio P., Luisi S., Ciarmela P., Severi F.M., Bocchi C., Petraglia F. Inhibins and activins in pregnancy. Mol. Cell. Endocrinol. 2004; 225(1-2): 93-100.
  8. Florio P., Severi F.M., Bocchi C., Luisi S., Mazzini M., Danero S. et al. Single serum activin A testing to predict ectopic pregnancy. J. Clin. Endocrinol. Metab. 2007; 92(5): 1748-53.
  9. Fowler P.A., Evans L.W., Groome N.P., Templeton A., Knight P.G. A longitudinal study of maternal serum inhibin-A, inhibin-B, activin-A, activin-AB, pro-aC and follistatin during pregnancy. Hum. Reprod. 1998; 13(12): 3530-6.
  10. Kirk E., Papageorghiou A.T., Van Calster B., Condous G., Cowans N., Van Huffel S. et al. The use of serum inhibin A and activin A levels in predicting the outcome of “pregnancies of unknown location”. Hum. Reprod. 2009; 24(10): 2451-6.
  11. Kriebs J.M., Fahey J.O. Ectopic pregnancy. J. Midwifery Womens Health. 2006; 51(6): 431-9.
  12. Muttukrishna S., Jauniaux E., McGarrigle H., Groome N., Rodeck C.H. In-vivo concentrations of inhibins, activin A and follistatin in human early pregnancy. Reprod. BioMed. Online. 2004; 8(6): 712-9.
  13. Mukul L.V., Teal S.B. Current management of ectopic pregnancy. Obstet. Gynecol. Clin. N. Am. 2007; 34(3): 403-19.
  14. Shaw J.L.V., Horne A.W. The paracrinology of tubal ectopic pregnancy. Mol. Cell. Endocrinol. 2012; 358(2): 216-22.
  15. Sowter M.C., Farquhar C.M. Ectopic pregnancy: an update. Curr. Opin. Obstet. Gynecol. 2004; 16: 289-93.
  16. Qu J., Thomas K. Advance in the study of inhibin, activin and follistatin production in pregnant women. Eur. J. Obstet. Gynecol. Reprod. Biol. 1998; 81: 141-8.
  17. Warrick J., Gronowski A., Moffett C., Zhao Q., Bishop E., Woodworth A. Serum activin A does not predict ectopic pregnancy as a single measurement test, alone or as part of a multimarker panel including progesterone and hCG. Clin. Chim. Acta. 2012; 413(7-8): 707-11.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies